MedPath

Effect of combination therapy of EPA and DHA on arterial stiffness in type 2 diabetic patients with hypertriglyceridemia

Not Applicable
Conditions
Hypertriglyceridemia with type 2 diabetes
Registration Number
JPRN-UMIN000011206
Lead Sponsor
Toho University Sakura Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Severe hypertriglyceridemia (TG>1000mg/dl) Familial hypercholesterolemia Patients with allergy to DHA

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A change in CAVI(cardio-ankle vascular index)
Secondary Outcome Measures
NameTimeMethod
Changes in lipid metabolic parameters (total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, apoprotein, LPL mass)
© Copyright 2025. All Rights Reserved by MedPath